Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (5): 897-901. doi: 10.19723/j.issn.1671-167X.2020.05.017

Previous Articles     Next Articles

Multicenter performance of the different classification criteria for rheumatoid arthritis

Cai-nan LUO1,Zheng-fang LI1,Li-jun WU1,(),Hai-juan CHEN2,Chun-mei YANG2,Wen-hui XU3,Xiao-ling LIU4,Wei TANG2,Ping QIAO3,Baihetiya Rena4   

  1. 1. Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Ugyur Autonomous Region, Urumuqi 830001, China
    2. Department of Rheumatology and Immunology, People’s Hospital of Changji, Changji 831100, Xinjiang, China
    3. Department of Rheumatology and Immunology, People’s Hospital of Aletai Region, Aletai 836500, Xinjiang, China
    4. Department of Rheumatology and Immunology, First People’s Hospital of Kashgar Region, Kashgar 844000, Xinjiang, China
  • Received:2018-11-10 Online:2020-10-18 Published:2020-10-15
  • Contact: Li-jun WU E-mail:wwlj330@126.com

RICH HTML

  

Abstract:

Objective: To evaluate the classification criteria of early rheumatoid arthritis (ERA) and compare the sensitivity and specificity with the criteria of 1987 American College of Rheumatology (ACR) criteria and 2010 ACR/European League Against Rheumatism (EULAR). Methods: Patients from 4 hospitals, aged more than 16 years, with arthritis, whose disease duration was ≤1 year, and with ≥1 joint pain and swelling were enrolled in the study. The indicators including clinical manifestations, laboratory tests and imaging examinations were observed. The ERA patients were dignosed by two experienced rheumatologists based on the clinical features, drug therapy information and radiography features. Results: (1) A total of 325 patients with arthritis were enrolled, including 98 males (30.15%) and 227 females (69.85%), The average age was (47.53±14.44) years, and the median disease duration was 5 (2, 8) months. Finally, 236 patients were dignosed with ERA, and 89 patients were dignosed with other diseases (Non-ERA, including osteoarthritis, reactive arthritis, undifferentiated arthritis, spondyloarthritis, etc). (2) The sensitivity of ERA criteria was 87.29%, and the specificity was 84.37%. The sensitivity was higher than that of 1987 ACR criteria (χ 2=43.641, P<0.001), and had no significant difference compared with 2010 ACR/EULAR criteria (χ2=0.446, P=0.593). But the specificity of ERA criteria was lower than that of 1987 ACR criteria (χ2=4.891, P=0.027), which was not statistically significant compared with 2010 ACR/EULAR criteria (χ2=0.044, P=1.000). (3) In the patients with arthritis whose disease duration was ≤3 months and ≤6 months, the sensitivity of ERA criteria was 81.71% and 86.79%, respectively, both were higher than the 1987 ACR criteria (χ2=7.131, P=0.008; χ2=22.015, P<0.001) and had no statistically difference compared with the 2010 ACR/EULAR criteria (χ2=0.220,P=0.755; χ2=0.473,P=0.491). The differences of the three criteria in specificity were not statistically significant. (4) The three different classification criteria were consistent with the clinical diagnosis, among which the ERA criteria and 2010 ACR/EULAR criteria were slightly higher (Kappa>0.6). The results of the consistency comparison between the three criteria showed that the ERA criteria and 2010 ACR/EULAR criteria had a better consistency (Kappa=0.836). Conclusion: The sensitivity of ERA classification criteria in the diagnosis of ERA was higher than that of 1987 ACR criteria, and was equivalent to that of 2010 ACR/EULAR criteria. There is no significant difference in specificity between these three criteria. The ERA criteria can also identify patients with RA at a very early stage in arthritis with disease duration ≤3 months.

Key words: Arthritis, Rheumatoid arthritis, Early diagnosis

CLC Number: 

  • R593.22

Table 1

Clinical charasteristics of ERA and non-ERA patients"

Items ERA(n=236) Non-ERA(n=89) P
Male/female, n 60/176 38/51 0.002
Age/years, x-±s 49.59±13.85 44.89±15.70 0.001
Disease duration/months, median (IQR) 5(2.25, 8.00) 3(1.00,10.00) 0.068
Swollen joint count, median (IQR) 5(2, 10) 2(1, 4) <0.001
Tender joint count, median (IQR) 11(6, 20) 4(2, 10) <0.001
Morning stiffness(>30 min), n(%) 151(63.98) 14(15.73) <0.001
RF positive, n(%) 162(68.64) 8(8.99) <0.001
Anti-CCP positive, n(%) 183(77.54) 6(6.74) <0.001
ESR/(mm/h), median (IQR) 41.50(24.00, 59.75) 27.00(14.00, 54.00) 0.008
CRP/(mg/L), median (IQR) 11.60(4.60, 36.38) 10.11(2.00, 46.48) 0.287

Table 2

Clinical charasteristics of patients with arthritis whose disease duration ≤3 months and ≤6 months"

Items Disease duration≤3 months(n=129) Disease duration≤6 months(n=220) P
Male/female, n 43/86 74/146 0.954
Age/years, x-±s 47.09±15.89 49.80±14.16 0.345
Swollen joint count, median (IQR) 4(1, 8) 4(1, 9) 0.688
Tender joint count, median (IQR) 7(3, 14) 8(4, 18) 0.063
Morning stiffness(>30 min), n(%) 66(51.16) 115(52.27) 0.841
RF positive, n(%) 56(43.41) 115(52.27) 0.110
anti-CCP positive, n(%) 62(48.06) 125(56.82) 0.113
ESR, mm/h, median (IQR) 39.00(20.75, 58.00) 40.00(22.00, 58.25) 0.758
CRP, mg/L, median (IQR) 13.26(3.04, 44.79) 11.60(4.17, 42.40) 0.839

Table 3

Sensitivity and specificity of 3 classification criterias in patients with arthritis"

Classification criteria Sensitivity/% Specificity/% Positive predictive value/% Negative predictive value/%
ERA 87.29 84.27 93.64 71.43
1987 ACR 60.59 94.38 96.62 47.45
2010 ACR/EULAR 85.17 86.52 94.37 68.75

Table 4

Sensitivity and specificity of 3 classification criterias in arthritis patients with disease duration ≤3 months"

Classification criteria Sensitivity/% Specificity/% Positive predictive value/% Negative predictive value/%
ERA 81.71 91.49 94.37 74.14
1987 ACR 54.88 100.00 100.00 63.51
2010 ACR/EULAR 79.27 93.62 95.59 72.13

Table 5

Sensitivity and specificity of 3 classification criterias in arthritis patients with disease duration ≤6 months"

Classification criteria Sensitivity/% Specificity/% Positive predictive value/% Negative predictive value/%
ERA 86.79 90.12 94.52 77.66
1987 ACR 64.15 97.53 98.08 25.00
2010 ACR/EULAR 83.02 91.36 94.96 73.27

Table 6

Comparision of consistency between clinical diagnosis and 3 classification criterias"

Items Consistency
rate/%
Kappa P
Clinical diagnosis & ERA 86.46 0.678 <0.001
Clinical diagnosis & 1987 ACR 69.85 0.420 <0.001
Clinical diagnosis & 2010
ACR/EULAR
85.54 0.663 <0.001

Table 7

Comparision of consistency among 3 classification criterias"

Items Consistency
rate/%
Kappa P
ERA & 1987 ACR 78.15 0.577 <0.001
ERA & 2010 ACR/EULAR 92.31 0.836 <0.001
2010 ACR/EULAR & 1987 ACR 75.38 0.521 <0.001
[1] 赵金霞, 苏茵, 刘湘源, 等. 早期类风湿关节炎分类标准及其诊断意义的探讨[J]. 中华风湿病学杂志, 2012,16(10):651-656.
[2] Zhao J, Su Y, Li R, et al. Classification criteria of early rheumatoid arthritis and validation of its performance in a multi-centre cohort[J]. Clin Exp Rheumatol, 2014,32(5):667-673.
[3] 李玉翠, 范文强, 陈海英, 等. 2012年早期类风湿关节炎分类标准的国内多中心临床验证[J]. 中华风湿病学杂志, 2017,21(12):807-811.
[4] 叶华, 苏茵, 李茹, 等. 早期类风湿关节炎分类标准的全国多中心临床验证[J]. 中华风湿病学杂志, 2014,18(12):802-805.
[5] Ye H, Su Y, Li R, et al. Comparison of three classification criteria of rheumatoid arthritis in an inception early arthritis cohort[J]. Clin Rheumatol, 2016,35(10):2397-2401.
doi: 10.1007/s10067-016-3281-2 pmid: 27129710
[6] Radner H, Neogi T, Smolen JS, et al. Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: A systematic literature review[J]. Ann Rheum Dis, 2014,73(1):114-123.
doi: 10.1136/annrheumdis-2013-203284
[7] van der Linden MP, Knevel R, Huizinga TW, et al. Classification of rheumatoid arthritis: Comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria[J]. Arthritis Rheum, 2011,63(1):37-42.
doi: 10.1002/art.30100 pmid: 20967854
[8] Biliavska I, Stamm TA, Martinez-Avila J, et al. Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort[J]. Ann Rheum Dis, 2013,72(8):1335-1341.
doi: 10.1136/annrheumdis-2012-201909
[1] Dongwu LIU, Jie CHEN, Mingli GAO, Jing YU. Rheumatoid arthritis with Castleman-like histopathology in lymph nodes: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(5): 928-931.
[2] Zhengfang LI,Cainan LUO,Lijun WU,Xue WU,Xinyan MENG,Xiaomei CHEN,Yamei SHI,Yan ZHONG. Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 729-734.
[3] Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525.
[4] Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283.
[5] Hongguang LI,Weihua HAN,Xun WU,Jiling FENG,Gang LI,Juanhong MENG. Preliminarily study of arthrocentesis combined with liquid phase concentrated growth factor injection in the treatment of unilateral temporomandibular joint osteoarthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 338-344.
[6] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[7] Qi WU,Yue-ming CAI,Juan HE,Wen-di HUANG,Qing-wen WANG. Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 982-992.
[8] Jing-feng ZHANG,Yin-ji JIN,Hui WEI,Zhong-qiang YAO,Jin-xia ZHAO. Correlation analysis between body mass index and clinical characteristics of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 993-999.
[9] Yin-ji JIN,Lin SUN,Jin-xia ZHAO,Xiang-yuan LIU. Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 631-635.
[10] Wen-xin CAI,Shi-cheng LI,Yi-ming LIU,Ru-yu LIANG,Jing LI,Jian-ping GUO,Fan-lei HU,Xiao-lin SUN,Chun LI,Xu LIU,Hua YE,Li-zong DENG,Ru LI,Zhan-guo LI. A cross-sectional study on the clinical phenotypes of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1068-1073.
[11] Fang CHENG,Shao-ying YANG,Xing-xing FANG,Xuan WANG,Fu-tao ZHAO. Role of the CCL28-CCR10 pathway in monocyte migration in rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1074-1078.
[12] Rui LIU,Jin-xia ZHAO,Liang YAN. Clinical characteristics of patients with rheumatoid arthritis complicated with venous thrombosis of lower extremities [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1079-1085.
[13] Jing-feng ZHANG,Yin-ji JIN,Hui WEI,Zhong-qiang YAO,Jin-xia ZHAO. Cross-sectional study on quality of life and disease activity of rheumatoid arthritis patients [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1086-1093.
[14] GAO Chao,CHEN Li-hong,WANG Li,YAO Hong,HUANG Xiao-wei,JIA Yu-bo,LIU Tian. Validation of the Pollard’s classification criteria (2010) for rheumatoid arthritis patients with fibromyalgia [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 278-282.
[15] LOU Xue,LIAO Li,LI Xing-jun,WANG Nan,LIU Shuang,CUI Ruo-mei,XU Jian. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!